KWALITY PHARMACEUTICALS
|
The Current P/E Ratio of KWALITY PHARMACEUTICALS is 29.15.
| Share Price | ₹1,583.8 | Apr 21,2026 |
| Market Cap | ₹1,647.1 Cr | |
| Earnings-TTM | ₹56.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 29.15x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of KWALITY PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,647.1 Cr] as on Apr 21,2026
(/) Earnings [ ₹56.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 29.15x ]
Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay 29.15 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KWALITY PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KWALITY PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of KWALITY PHARMACEUTICALS
PE Ratio Performance Analysis for KWALITY PHARMACEUTICALS
- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.16x.
- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 16.47x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 22.63x.
- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 3.84x.
How does KWALITY PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| KWALITY PHARMACEUTICALS | 56.51 | 29.15 | 1,647.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 36.32 | 399,549.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 67.31 | 166,862.0 |
| CIPLA LTD | 4,544.70 | 21.91 | 99,591.5 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 61.58 | 139,912.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.50 | 101,891.0 |
| MANKIND PHARMA LTD | 1,796.65 | 50.45 | 90,642.6 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.94 | 93,464.0 |
| LUPIN LTD | 4,669.18 | 22.64 | 105,688.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 23.00 | 80,798.2 |
| ABBOTT INDIA LTD | 1,524.13 | 35.40 | 53,961.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KWALITY PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.50x |
| Max industry PE | 67.31x |
| Median industry PE | 29.15x |
| Average industry PE | 35.02x |
You may also like the below Video Courses